title: Beta-adrenergic signaling, a novel target for cancer therapy?
authors.forename: Hildegard M
authors.initials: HM
authors.lastname: Schuller
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D058990:Molecular Targeted Therapy / Q000379:methods* / Q000639:trends; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000378:metabolism / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016019:Survival Analysis
chemical_list: D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents; D011943:Receptors, Adrenergic, beta; D011433:Propranolol